Targeting mechanosignaling to improve treatments for pediatric brain cancer

Targeting mechanosignaling in pediatric brain cancer

NIH-funded research Nemours Children's Hospital, Delaware · NIH-11032821

This study is working on finding better treatments for kids with brain cancer, especially medulloblastoma, by using special 3D models that closely resemble how tumors grow in the body, which helps researchers discover new medicines that could improve care for young patients.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionNemours Children's Hospital, Delaware NIH-funded
Lab location1 site (Wilmington, United States)
Project IDNIH-11032821 on NIH RePORTER

What this research studies

This research focuses on developing more effective therapies for pediatric brain cancer, particularly medulloblastoma, by targeting mechanosensitive signaling pathways. It utilizes advanced three-dimensional (3D) cell cultures that better mimic the natural environment of tumors, allowing for more accurate drug testing. By creating a more realistic model of tumor behavior, the research aims to identify new anti-cancer agents that can improve treatment outcomes for young patients. The approach seeks to overcome limitations of traditional cell culture methods that do not adequately represent the tumor microenvironment.

Who could benefit from this research

Good fit: Ideal candidates for this research are children diagnosed with medulloblastoma or other types of pediatric brain cancer.

Not a fit: Patients with brain cancers that are not medulloblastoma or those who are not eligible for experimental therapies may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to more effective treatments for pediatric brain cancer, potentially reducing mortality and long-term side effects for survivors.

How similar studies have performed: Previous research has shown promise in using 3D cell cultures for drug discovery in cancer treatment, indicating that this approach could be effective.

Where this research is happening

Wilmington, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions Anti-Cancer Agentsanti-cancer drug
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.